Skip to main navigation Skip to search Skip to main content

Pharmacokinetics, tolerability, and preliminary efficacy of paquinimod (ABR-215757), a new quinoline-3-carboxamide derivative: Studies in lupus-prone mice and a multicenter, randomized, double-blind, placebo-controlled, repeat-dose, dose-ranging study in patients with systemic lupus erythematosus

Anders Bengtsson, Gunnar Sturfelt, Christian Lood, Lars Ronnblom, Ronald F. van Vollenhoven, Bengt Axelsson, Birgitta Sparre, Helen Tuvesson, Marie Wallen Ohman, Tomas Leanderson

Research output: Contribution to journal › Article › peer-review

Fingerprint

Dive into the research topics of 'Pharmacokinetics, tolerability, and preliminary efficacy of paquinimod (ABR-215757), a new quinoline-3-carboxamide derivative: Studies in lupus-prone mice and a multicenter, randomized, double-blind, placebo-controlled, repeat-dose, dose-ranging study in patients with systemic lupus erythematosus'. Together they form a unique fingerprint.
Sort by

Pharmacology, Toxicology and Pharmaceutical Science